N-acetylglucosamine-1-phosphate uridyltransferase
From Proteopedia
(Difference between revisions)
(New page: <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> == Function == '''N-acetylglucosamine-1-phosphate uridyltransferase''' (GlmU} or '''...) |
|||
| Line 1: | Line 1: | ||
| - | |||
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''> | ||
| Line 9: | Line 8: | ||
== Relevance == | == Relevance == | ||
| + | |||
| + | GlmU is essencial The inhibition of GlmU is a potential anti-tuberculosis drug target<ref>PMID:3=18573680</ref>. | ||
== Structural highlights == | == Structural highlights == | ||
Revision as of 06:37, 13 April 2020
| |||||||||||
3D structures of GlmU
Updated on 13-April-2020
References
- ↑ Zhang Z, Bulloch EM, Bunker RD, Baker EN, Squire CJ. Structure and function of GlmU from Mycobacterium tuberculosis. Acta Crystallogr D Biol Crystallogr. 2009 Mar;65(Pt 3):275-83. Epub 2009, Feb 20. PMID:19237750 doi:10.1107/S0907444909001036
- ↑ PMID:3=18573680
